title: Factors influencing prognosis after dose-intensive therapy for recurrent or refractory Hodgkin's disease. Results of sequential trials: a case for treating patients with resistant disease.
authors.affiliation: Division of Oncology and Hematology, New York Medical College, Valhalla 10595, USA.
authors.forename: T
authors.initials: T
authors.lastname: Ahmed
authors.forename: D
authors.initials: D
authors.lastname: Lake
authors.forename: E
authors.initials: E
authors.lastname: Feldman
authors.forename: K
authors.initials: K
authors.lastname: Seiter
authors.forename: L
authors.initials: L
authors.lastname: Helson
authors.forename: A
authors.initials: A
authors.lastname: Mittelman
authors.forename: C
authors.initials: C
authors.lastname: Puccio
authors.forename: H
authors.initials: H
authors.lastname: Chun
authors.forename: K
authors.initials: K
authors.lastname: Grima
authors.forename: T
authors.initials: T
authors.lastname: Akhtar
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D016190:Carboplatin / Q000008:administration & dosage; D002330:Carmustine / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D004351:Drug Resistance; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D011379:Prognosis; D012008:Recurrence; D015996:Survival Rate; D013852:Thiotepa / Q000008:administration & dosage; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014747:Vinblastine; D005047:Etoposide; D003520:Cyclophosphamide; D013852:Thiotepa; D016190:Carboplatin; D008942:Mitoxantrone; D002330:Carmustine